Eric W.‐F. Lam

30.8k total citations · 5 hit papers
298 papers, 23.1k citations indexed

About

Eric W.‐F. Lam is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Eric W.‐F. Lam has authored 298 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 212 papers in Molecular Biology, 92 papers in Oncology and 50 papers in Immunology. Recurrent topics in Eric W.‐F. Lam's work include FOXO transcription factor regulation (99 papers), Cancer-related Molecular Pathways (44 papers) and Ubiquitin and proteasome pathways (24 papers). Eric W.‐F. Lam is often cited by papers focused on FOXO transcription factor regulation (99 papers), Cancer-related Molecular Pathways (44 papers) and Ubiquitin and proteasome pathways (24 papers). Eric W.‐F. Lam collaborates with scholars based in United Kingdom, United States and China. Eric W.‐F. Lam's co-authors include Stephen S. Myatt, Jan J. Brosens, Ana Gomes, Francesco Dazzi, R. Charles Coombes, Inês Soeiro, Chuay-Yeng Koo, René H. Medema, Boudewijn Burgering and R J Watson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Eric W.‐F. Lam

290 papers receiving 22.8k citations

Hit Papers

Bone marrow mesenchymal s... 2000 2026 2008 2017 2005 2007 2013 2000 2020 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eric W.‐F. Lam 15.3k 5.4k 4.0k 3.5k 2.1k 298 23.1k
Hong Wu 16.6k 1.1× 7.2k 1.3× 4.5k 1.1× 3.1k 0.9× 2.1k 1.0× 204 26.2k
C. Patrick Reynolds 12.7k 0.8× 5.0k 0.9× 4.8k 1.2× 2.6k 0.7× 1.4k 0.7× 338 21.8k
Zora Modrušan 10.6k 0.7× 4.9k 0.9× 3.6k 0.9× 5.0k 1.4× 2.2k 1.1× 166 19.7k
Philip N. Tsichlis 14.4k 0.9× 4.6k 0.9× 3.9k 1.0× 4.9k 1.4× 944 0.5× 196 21.5k
Stanisław Krajewski 15.2k 1.0× 5.4k 1.0× 2.7k 0.7× 3.4k 1.0× 1.2k 0.6× 183 22.9k
Nissim Hay 20.2k 1.3× 4.9k 0.9× 6.5k 1.6× 3.0k 0.9× 1.0k 0.5× 160 27.9k
Ruggero De Maria 13.1k 0.9× 9.1k 1.7× 6.1k 1.5× 4.0k 1.1× 2.0k 1.0× 257 22.8k
Masabumi Shibuya 12.6k 0.8× 4.8k 0.9× 3.8k 0.9× 2.7k 0.8× 922 0.4× 215 20.7k
Keiko Nakayama 15.7k 1.0× 6.9k 1.3× 2.5k 0.6× 3.7k 1.1× 1000 0.5× 286 23.3k
Steven Grant 16.7k 1.1× 6.3k 1.2× 2.3k 0.6× 2.2k 0.6× 1.7k 0.8× 451 23.2k

Countries citing papers authored by Eric W.‐F. Lam

Since Specialization
Citations

This map shows the geographic impact of Eric W.‐F. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric W.‐F. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric W.‐F. Lam more than expected).

Fields of papers citing papers by Eric W.‐F. Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric W.‐F. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric W.‐F. Lam. The network helps show where Eric W.‐F. Lam may publish in the future.

Co-authorship network of co-authors of Eric W.‐F. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Eric W.‐F. Lam. A scholar is included among the top collaborators of Eric W.‐F. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric W.‐F. Lam. Eric W.‐F. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fraser, M, et al.. (2025). Rapidly Fatal Hemophagocytic Lymphohistiocytosis Secondary to Influenza in a Young Adult With Sickle Cell Disease. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5904–A5904.
2.
Lam, Eric W.‐F., et al.. (2025). A chemically tunable FOXM1–DHFR sensor reveals the direct influence of FOXM1 on the cell cycle. Journal of Cell Science. 138(14).
3.
Wu, Zheng, Xinyue Liu, Fang Xie, et al.. (2024). Comprehensive pan-cancer analysis identifies the RNA-binding protein LRPPRC as a novel prognostic and immune biomarker. Life Sciences. 343. 122527–122527. 6 indexed citations
4.
Cui, Bai, Bin He, Yanping Huang, et al.. (2023). Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress. Cell Death and Disease. 14(10). 682–682. 17 indexed citations
5.
Wen, Shijun, Fang Liu, Zijian Zhang, et al.. (2021). CRISPR/Cas9 screening identifies a kinetochore‐microtubule dependent mechanism for Aurora‐A inhibitor resistance in breast cancer. Cancer Communications. 41(2). 121–139. 30 indexed citations
6.
Gong, Chun, Ellen P.S. Man, Ho Tsoi, et al.. (2018). BQ323636.1, a Novel Splice Variant to NCOR 2, as a Predictor for Tamoxifen-Resistant Breast Cancer. Clinical Cancer Research. 24(15). 3681–3691. 19 indexed citations
7.
Saavedra-García, Paula, et al.. (2017). Unravelling the role of fatty acid metabolism in cancer through the FOXO3-FOXM1 axis. Molecular and Cellular Endocrinology. 462(Pt B). 82–92. 24 indexed citations
8.
Zheng, Fei-Meng, Caifeng Yue, Guohui Li, et al.. (2016). Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype. Nature Communications. 7(1). 10180–10180. 146 indexed citations
9.
Ghaem‐Maghami, Sadaf, Roberta Bortolozzi, Stefania Zona, et al.. (2015). FOXO3a and Posttranslational Modifications Mediate Glucocorticoid Sensitivity in B-ALL. Molecular Cancer Research. 13(12). 1578–1590. 27 indexed citations
10.
Olano, Natalia de, Chuay-Yeng Koo, Lara J. Monteiro, et al.. (2012). The p38 MAPK–MK2 Axis Regulates E2F1 and FOXM1 Expression after Epirubicin Treatment. Molecular Cancer Research. 10(9). 1189–1202. 47 indexed citations
11.
McKie, Arthur B., Sebastian Vaughan, Imoh S. Okon, et al.. (2012). The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer. Cancer Discovery. 2(2). 156–171. 41 indexed citations
12.
Siu, Michelle K.Y., Oscar Gee‐Wan Wong, Xin Lü, et al.. (2011). iASPP and Chemoresistance in Ovarian Cancers: Effects on Paclitaxel-Mediated Mitotic Catastrophe. Clinical Cancer Research. 17(21). 6924–6933. 63 indexed citations
13.
Millour, Julie, Natalia de Olano, Yoshiya Horimoto, et al.. (2011). ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance. Molecular Cancer Therapeutics. 10(6). 1046–1058. 132 indexed citations
14.
Peck, Barrie, Chun‐Yuan Chen, Ka-Kei Ho, et al.. (2010). SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2. Molecular Cancer Therapeutics. 9(4). 844–855. 371 indexed citations
15.
Kwok, Jimmy M-M., Barrie Peck, Lara J. Monteiro, et al.. (2010). FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells. Molecular Cancer Research. 8(1). 24–34. 167 indexed citations
16.
Myatt, Stephen S., Jun Wang, Lara J. Monteiro, et al.. (2009). Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial Cancer. Cancer Research. 70(1). 367–377. 284 indexed citations
17.
McGovern, Ursula, Richard E. Francis, Barrie Peck, et al.. (2009). Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Molecular Cancer Therapeutics. 8(3). 582–591. 115 indexed citations
18.
Gomes, Ana, Demetra Constantinidou, Joana R. Costa, et al.. (2008). The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression. Molecular and Cellular Biology. 28(19). 5886–5898. 127 indexed citations
19.
Cloke, Brianna, Kaisa Huhtinen, Luca Fusi, et al.. (2008). The Androgen and Progesterone Receptors Regulate Distinct Gene Networks and Cellular Functions in Decidualizing Endometrium. Endocrinology. 149(9). 4462–4474. 127 indexed citations
20.
Labied, Soraya, Takeshi Kajihara, Patrícia A. Madureira, et al.. (2005). Progestins Regulate the Expression and Activity of the Forkhead Transcription Factor FOXO1 in Differentiating Human Endometrium. Molecular Endocrinology. 20(1). 35–44. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026